Apple Skips TSMC's 2nm Chip For iPhone 17, Unveils First iOS 18 Public Beta And More: This Week In Appleverse
Portfolio Pulse from Benzinga Neuro
Apple had a busy week with several key developments. The company decided to skip TSMC's 2nm chip for the iPhone 17, opting for a refined 3nm chip instead. Apple also rolled out the first iOS 18 public beta, received a favorable ruling on its redesigned ECG for the Apple Watch, and approved the first PC emulator for iPhone and iPad. Analyst Ming-Chi Kuo expressed doubts about the iPhone 16 sales projections.
July 21, 2024 | 11:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apple decided to skip TSMC's 2nm chip for the iPhone 17, opting for a refined 3nm chip. The company also rolled out the first iOS 18 public beta, received a favorable ruling on its redesigned ECG for the Apple Watch, and approved the first PC emulator for iPhone and iPad. Analyst Ming-Chi Kuo expressed doubts about the iPhone 16 sales projections.
Apple's decision to skip the 2nm chip may indicate a focus on stability and performance, which could be seen positively by investors. The rollout of iOS 18 public beta and the approval of the PC emulator show continued innovation. The favorable ruling on the ECG patent case removes a legal hurdle. However, the doubts expressed by analyst Ming-Chi Kuo about iPhone 16 sales could temper some of the positive sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Apple will not be using TSMC's 2nm chip for the iPhone 17, opting instead for a refined 3nm chip. This decision could impact TSMC's future revenue projections and market perception.
Apple's decision to skip TSMC's 2nm chip could be seen as a setback for TSMC, potentially affecting its future revenue and market perception. The choice to use a refined 3nm chip instead may indicate concerns about the readiness or performance of the 2nm technology.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70